Stryker Corporation is a leading medical technology company that specializes in designing, manufacturing, and marketing innovative products and services for healthcare professionals and patients. The company offers a diverse range of medical devices, including surgical equipment, orthopedic implants, neurotechnology, and surgery assistance products. Stryker focuses on advancing healthcare through cutting-edge technology and solutions that enhance patient care, improve surgical outcomes, and streamline hospital operations. With a commitment to innovation and quality, Stryker plays a pivotal role in the medical industry, helping healthcare providers deliver effective treatment and improve the quality of life for patients around the world. Read More
Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.02% on an annualized basis producing an average annual return of 10.41%. Currently, Stryker has a market capitalization of $129.84 billion.
Stryker’s second quarter results met Wall Street’s revenue expectations, yet the market responded negatively, reflecting investor concerns about the company’...
Portage, Michigan, Aug. 05, 2026 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced that its Board of Directors has declared a quarterly dividend of $0.88 per share payable July 31, 2026, to shareholders of record at the close of business on June 30, 2026, representing an increase of 4.8% versus the prior year and unchanged from the previous quarter.
Stryker (NYSE:SYK) reported 9% organic sales growth in the second quarter of 2026 and adjusted earnings per share growth of 17.9%, as the medical technology company continued recovering from a cybersecurity incident that disrupted operations earlier in the year.
Chair and CEO Kevin Lobo said the co
What Happened? Shares of medical technology company Stryker (NYSE:SYK) fell 7.3% in the morning session after the company reported second-quarter results tha...
Medical technology company Stryker (NYSE:SYK) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $6.59 billion. Its non-...
Medical technology company Stryker (NYSE:SYK) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 9.4% year on year to $6.59 billion. Its non-...
Medical technology company Stryker (NYSE:SYK) will be reporting earnings this Thursday afternoon. Here’s what investors should know. Stryker missed analysts’...
Stryker (NYSE:SYK) has outperformed the market over the past 20 years by 1.04% on an annualized basis producing an average annual return of 10.3%. Currently, Stryker has a market capitalization of $122.02 billion.